{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:35:33Z","timestamp":1790660133011,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007446","name":"King Khalid University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007446","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023674","name":"King Khalid University Deanship of Scientific Research","doi-asserted-by":"publisher","award":["RGP.1\/193\/46"],"award-info":[{"award-number":["RGP.1\/193\/46"]}],"id":[{"id":"10.13039\/501100023674","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.bbrc.2026.153540","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T16:26:00Z","timestamp":1772727960000},"page":"153540","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Integrated discovery of SBLR876: a potent RAGE inhibitor mitigating AGE\u2013RAGE\u2013NF-\u03baB-mediated cytotoxicity and inflammation in diabetic kidney disease"],"prefix":"10.1016","volume":"811","author":[{"given":"Mesfer","family":"Mohammad AL Shahrani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Abohassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayed A.","family":"Dera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sivakumar","family":"Vijayaraghavalu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7593-7234","authenticated-orcid":false,"given":"Prasanna","family":"Rajagopalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.153540_bib1","article-title":"Diabetic kidney disease","volume":"1","author":"Thomas","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.bbrc.2026.153540_bib2","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.2215\/CJN.11491116","article-title":"Diabetic kidney disease: challenges, progress, and possibilities","volume":"12","author":"Alicic","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol. : CJASN"},{"key":"10.1016\/j.bbrc.2026.153540_bib3","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.2337\/dci23-0030","article-title":"Diabetic nephropathy: update on pillars of therapy slowing progression","volume":"46","author":"Naaman","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbrc.2026.153540_bib4","article-title":"Targeting ion channel networks in diabetic kidney disease: from molecular crosstalk to precision therapeutics and clinical innovation","volume":"12","author":"Wang","year":"2025","journal-title":"Front. Med."},{"key":"10.1016\/j.bbrc.2026.153540_bib5","article-title":"The receptor for advanced glycation endproducts (RAGE) and cardiovascular disease","volume":"11","author":"Yan","year":"2009","journal-title":"Expet Rev. Mol. Med."},{"key":"10.1016\/j.bbrc.2026.153540_bib6","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.freeradbiomed.2021.05.025","article-title":"AGE\/RAGE in diabetic kidney disease and ageing kidney","volume":"171","author":"Wu","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbrc.2026.153540_bib7","article-title":"Targeting the AGEs-RAGE axis: pathogenic mechanisms and therapeutic interventions in diabetic wound healing","volume":"12","author":"Lin","year":"2025","journal-title":"Front. Med."},{"key":"10.1016\/j.bbrc.2026.153540_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/biom12040542","article-title":"Advanced glycation end products and diabetes mellitus: mechanisms and perspectives","volume":"12","author":"Khalid","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbrc.2026.153540_bib9","first-page":"1","article-title":"AGE-RAGE stress, stressors, and antistressors in health and disease","volume":"27","author":"Prasad","year":"2018","journal-title":"Int. J. Angiol. : official publication of the International College of Angiology, Inc"},{"key":"10.1016\/j.bbrc.2026.153540_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107282","article-title":"Activation and modulation of the AGEs-RAGE axis: implications for inflammatory pathologies and therapeutic interventions - a review","volume":"206","author":"Zhou","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbrc.2026.153540_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.931473","article-title":"Pathophysiology of RAGE in inflammatory diseases","volume":"13","author":"Dong","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2026.153540_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27154922","article-title":"Receptor for advanced glycation end products (RAGE): a pivotal hub in immune diseases","volume":"27","author":"Yue","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bbrc.2026.153540_bib13","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.ekir.2021.04.023","article-title":"Chronic inflammation in chronic kidney disease progression: role of Nrf2","volume":"6","author":"Stenvinkel","year":"2021","journal-title":"Kidney Int. Rep."},{"key":"10.1016\/j.bbrc.2026.153540_bib14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s13167-010-0004-7","article-title":"Inflammatory cytokines as predictive markers for early detection and progression of diabetic nephropathy","volume":"1","author":"Elmarakby","year":"2010","journal-title":"EPMA J."},{"key":"10.1016\/j.bbrc.2026.153540_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1128872","article-title":"RAGE signaling regulates the progression of diabetic complications","volume":"14","author":"Taguchi","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.153540_bib16","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nri1594","article-title":"High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal","volume":"5","author":"Lotze","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbrc.2026.153540_bib17","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12979-017-0095-2","article-title":"Age dependent accumulation patterns of advanced glycation end product receptor (RAGE) ligands and binding intensities between RAGE and its ligands differ in the liver, kidney, and skeletal muscle","volume":"14","author":"Son","year":"2017","journal-title":"Immun. Ageing : Ir. Am."},{"key":"10.1016\/j.bbrc.2026.153540_bib18","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S0002-9440(10)63909-0","article-title":"RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy","volume":"162","author":"Wendt","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbrc.2026.153540_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.970423","article-title":"RAGE pathway activation and function in chronic kidney disease and COVID-19","volume":"9","author":"Curran","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.bbrc.2026.153540_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abf7084","article-title":"Small-molecule antagonism of the interaction of the RAGE cytoplasmic domain with DIAPH1 reduces diabetic complications in mice","volume":"13","author":"Manigrasso","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbrc.2026.153540_bib21","first-page":"17","article-title":"Absorption distribution metabolism excretion and toxicity property prediction utilizing a pre-trained natural language processing model and its applications in early-stage drug development","author":"Jung","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bbrc.2026.153540_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16213607","article-title":"Computer-aided identification and design of ligands for multi-targeting inhibition of a molecular acute myeloid leukemia network","volume":"16","author":"Asfa","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.bbrc.2026.153540_bib23","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s12032-022-01846-1","article-title":"Insilco and invitro approaches identify novel dual PI3K\/AKT pathway inhibitors to control acute myeloid leukemia cell proliferations","volume":"39","author":"Abohassan","year":"2022","journal-title":"Medical oncology (Northwood, London, England)"},{"key":"10.1016\/j.bbrc.2026.153540_bib24","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1021\/acs.jcim.0c00675","article-title":"ZINC20-A free ultralarge-scale chemical database for ligand discovery","volume":"60","author":"Irwin","year":"2020","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bbrc.2026.153540_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2025.151685","article-title":"Discovering the natural source-derived antihypertensive compounds aspiring current therapeutic targets by computer-based drug design","volume":"759","author":"Besli","year":"2025","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2026.153540_bib26","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","article-title":"gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS","volume":"17","author":"Vald\u00e9s-Tresanco","year":"2021","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.bbrc.2026.153540_bib27","first-page":"40","article-title":"ADMET-AI: a machine learning ADMET platform for evaluation of large-scale chemical libraries","author":"Swanson","year":"2024","journal-title":"Bioinformatics"},{"key":"10.1016\/j.bbrc.2026.153540_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.151225","article-title":"Identification of 8-(2-methyl phenyl)-9H-benzo[f]indeno[2,1-c]quinolin-9-one (C-5635020) as a novel and selective TGF\u03b2 RII kinase inhibitor for breast cancer therapy","volume":"746","author":"Al Shahrani","year":"2025","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2026.153540_bib29","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1749-6632.2011.06320.x","article-title":"Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications","volume":"1243","author":"Ramasamy","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbrc.2026.153540_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13061424","article-title":"Pathogenesis and therapeutic perspectives of tubular injury in diabetic kidney disease: an update","volume":"13","author":"Geng","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.bbrc.2026.153540_bib31","article-title":"Diabetic kidney disease: from pathogenesis to multimodal therapy-current evidence and future directions","volume":"12","author":"Zhang","year":"2025","journal-title":"Front. Med."},{"key":"10.1016\/j.bbrc.2026.153540_bib32","doi-asserted-by":"crossref","first-page":"386","DOI":"10.4093\/dmj.2025.0220","article-title":"SGLT2 inhibitors and GLP-1 receptor agonists in diabetic kidney disease: evolving evidence and clinical application","volume":"49","author":"Bae","year":"2025","journal-title":"Diabetes & metabolism journal"},{"key":"10.1016\/j.bbrc.2026.153540_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1264497","article-title":"Treatment and practical considerations of diabetic kidney disease","volume":"10","author":"Bilen","year":"2023","journal-title":"Front. Med."},{"key":"10.1016\/j.bbrc.2026.153540_bib34","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1007\/s11064-017-2321-x","article-title":"RAGE-specific inhibitor FPS-ZM1 attenuates AGEs-Induced neuroinflammation and oxidative stress in rat primary microglia","volume":"42","author":"Shen","year":"2017","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbrc.2026.153540_bib35","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1111\/febs.17086","article-title":"RAGE induces physiological activation of NADPH oxidase in neurons and astrocytes and neuroprotection","volume":"291","author":"Seryogina","year":"2024","journal-title":"FEBS J."},{"key":"10.1016\/j.bbrc.2026.153540_bib36","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6823058","article-title":"AGE\/RAGE-Induced EMP release via the NOX-derived ROS pathway","volume":"2018","author":"Chen","year":"2018","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.bbrc.2026.153540_bib37","doi-asserted-by":"crossref","first-page":"19891","DOI":"10.3390\/ijms141019891","article-title":"Radical roles for RAGE in the pathogenesis of oxidative stress in cardiovascular diseases and beyond","volume":"14","author":"Daffu","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.153540_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/nu17050758","article-title":"The potential role of advanced glycation end products in the development of kidney disease","volume":"17","author":"Ma","year":"2025","journal-title":"Nutrients"},{"key":"10.1016\/j.bbrc.2026.153540_bib39","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2147\/IJNRD.S436791","article-title":"The molecular mechanism of renal tubulointerstitial inflammation promoting diabetic nephropathy","volume":"16","author":"Xue","year":"2023","journal-title":"Int. J. Nephrol. Renovascular Dis."},{"key":"10.1016\/j.bbrc.2026.153540_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108117","article-title":"FPS-ZM1 inhibits LPS-Induced microglial inflammation by suppressing JAK\/STAT signaling pathway","volume":"100","author":"Wang","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbrc.2026.153540_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25115798","article-title":"Targeting NF-\u03baB signaling: selected small molecules downregulate pro-inflammatory cytokines in both food allergen and LPS-induced inflammation","volume":"25","author":"Zlatanova","year":"2024","journal-title":"Int. J. Mol. Sci."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26003049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26003049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T14:50:48Z","timestamp":1776610248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26003049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":41,"alternative-id":["S0006291X26003049"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153540","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrated discovery of SBLR876: a potent RAGE inhibitor mitigating AGE\u2013RAGE\u2013NF-\u03baB-mediated cytotoxicity and inflammation in diabetic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153540","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"153540"}}